| Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer | Kezban BERBEROĞLU | 50–62 |
| Morphologic and Metabolic Comparison of Treatment Responsiveness with 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type | Mehmet Fatih BÖRKSÜZ,TANER ERSELCAN,ZEKİYE HASBEK,BİRSEN YÜCEL,BÜLENT TURGUT | 63–69 |
| Evaluation of Silent Myocardial Ischemia with Single-Photon Emission Computed Tomography/Computed Tomography in Asymptomatic Subjects with Diabetes and Pre-Diabetes | Elif ÖZDEMİR,Şefika Burçak POLAT,Nilüfer YILDIRIM,ŞEYDA TÜRKÖLMEZ,Reyhan ERSOY,TAHİR DURMAZ,TELAT KELEŞ,Engin BOZKURT,BEKİR ÇAKIR | 70–78 |
| Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success? | ZEKİYE HASBEK,BÜLENT TURGUT | 79–84 |
| Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up | Filiz HATİPOĞLU,İnanç KARAPOLAT,ÖZGÜR ÖMÜR,AYŞEGÜL AKGÜN,Ahmet YANARATEŞ,Kamil KUMANLIOĞLU | 85–90 |
| Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? | Alexandra NİKAKİ,Athanasio ALEXOPOULOS,Fani VLACHOU,Vasilik FİLİPPİ,Ioannis ANDREOU,Vasiliki RAPTİ,Konstantinos GOGOS,Konstantinos DALİANİS,Roxani EFTHYMİADOU,Vassilios PRASSOPOULOS | 91–96 |
| Sentinel Lymph Node Detection by 3D Freehand Single-Photon Emission Computed Tomography in Early Stage Breast Cancer | Salih Sinan GÜLTEKİN,AHMET OĞUZ HASDEMİR,Serhat TOKGÖZ,Gülay ÖZGEHAN,Hakan GÜZEL,CÜNEYT YÜCESOY,Emine ÖZTÜRK,Ata Türker ARIKÖK | 97–101 |
| Kikuchi Disease with Generalized Lymph Node, Spleen and Subcutaneous Involvement Detected by Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography | Alshaima ALSHAMMARİ,Evangelia SKOURA,Nafisa KAZEM,Rasha ASHKANANİ | 102–106 |